Immune Support
|
February 13, 2025

Nitrofurantoin Explained: Uses, Dosage, and Side Effects

Written By
Dr. Jaime Cloyd ND
Medically Reviewed by
Updated On
February 21, 2025

Urinary tract infections (UTIs) are one of the most common bacterial infections worldwide: a whopping 404.61 million cases were estimated to have occurred in 2019. Although various antibiotics can treat these infections, nitrofurantoin has long been a top choice for doctors when treating uncomplicated UTIs. It is often recommended as a first-line treatment in medical guidelines due to its effectiveness, low resistance rates, and minimal side effects.

This article will explain everything you need to know about nitrofurantoin, from how it works to how to use it safely while minimizing side effects.

[signup]

What Is Nitrofurantoin?

Nitrofurantoin is an FDA-approved antibiotic for treating lower UTIs (cystitis) and has been in clinical use since 1953. Its effectiveness and low potential for causing bacterial resistance make it a standard treatment option in current medical practice.

Nitrofurantoin is the generic version of the brand-name medications Macrobid®, Macrodantin®, and Furadantin®.

  • Macrobid®: Available as 100 mg capsules. It contains nitrofurantoin macrocrystals and nitrofurantoin monohydrate, which work together to release the medication more slowly and prevent gastrointestinal side effects.
  • Macrodantin®: Available as 25, 50, or 100 mg capsules. It contains only nitrofurantoin macrocrystals.
  • Furadantin®: Available as an oral liquid suspension in concentrations of 25 mg/5 mL or 50 mg/5 mL.

Indications and Uses

Nitrofurantoin is FDA-approved to treat and prevent uncomplicated UTIs caused by susceptible strains of pathogenic bacteria residing in the urinary tract, including: 

  • Escherichia coli
  • Enterococci
  • Klebsiella
  • Staphylococcus saprophyticus and aureus
  • Enterobacter

How Nitrofurantoin Works

Nitrofurantoin works by disrupting the bacteria's ability to produce proteins and other molecules essential for their growth.

Mechanism of Action

After oral administration, nitrofurantoin is absorbed in the small intestine and enters the bloodstream. It is rapidly excreted by the kidneys into urine, where it is actively taken up by bacterial cells. Inside the bacterial cell, nitrofurantoin undergoes reduction by bacterial enzymes to form reactive metabolites or intermediates. 

These intermediates are highly reactive. They bind to bacterial ribosomes, the machinery responsible for protein synthesis. This binding interferes with the synthesis of proteins, enzymes, and cell wall components, all of which bacteria need for growth, replication, and survival. By disrupting these metabolic processes, nitrofurantoin prevents bacteria from multiplying and ultimately leads to their death.

Benefits Over Other Antibiotics

Unlike other antibiotics traditionally used as first-line treatments for uncomplicated UTIs, such as trimethoprim-sulfamethoxazole, which are experiencing rising resistance rates, nitrofurantoin continues to have low resistance rates. This is likely due to its broad-based mechanism of action, which affects multiple bacterial processes.

Nitrofurantoin also has high solubility in urine, which allows it to achieve therapeutic concentrations in the urinary tract while maintaining low systemic levels. The advantage of this urinary concentration is twofold: 

  • It ensures that nitrofurantoin reaches bactericidal (bacteria-killing) levels in the urine, where it is needed to treat UTIs
  • Low systemic levels minimize the risk of side effects

Dosage and Administration

The dosage information provided here is based on general guidelines. It is important to never adjust your dosage without consulting your doctor. Your healthcare provider will determine the appropriate dosage based on your specific health needs, medical history, and any other medications you may be taking. 

Standard Dosages

Treatment for Adults:

  • Macrobid® and Its Generic Form: 100 mg twice daily for five days
  • Macrodantin® and Its Generic Form: 50 mg four times daily for five days 

Prevention for Adults:

Treatment for Children:

  • Macrobid® and Its Generic Form: Approved for children 12 years and older. Dose 100 mg twice daily for seven days.
  • Macrodantin® and Its Generic Form: Approved for infants and children 1 month and older. Dose 5-7 mg/kg body weight divided into four equal doses daily for seven days.
  • Furandantin® and Its Generic Form: Approved for infants and children 1 month and older. Dose 5-7 mg/kg body weight divided into four equal doses daily for seven days.

How to Take Nitrofurantoin

Nitrofurantoin should be taken with food to help your body absorb it better. Research shows that the drug's urinary concentrations increase by 40% when taken with food.

Taking it with food or milk can also help reduce gastrointestinal discomfort, one of nitrofurantoin's most commonly reported side effects.

Side Effects and Risks

Nitrofurantoin is generally considered safe, though, like any medication, it can cause side effects. The side effect profile of nitrofurantoin is well-documented, and patients should be aware of potential risks:

Common Side Effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Loss of appetite
  • Headache
  • Dizziness
  • Skin rashes or itching

Serious Risks

  • Pulmonary Toxicity: Symptoms include fever, chills, cough, muscle pain, difficulty breathing, and dry cough.
  • Liver Injury: Signs and symptoms include elevations in serum aminotransferase levels, jaundice (yellowing of the skin and whites of the eyes), hepatitis, and liver failure. Preexisting liver disease increases the risk of drug-induced liver toxicity. 
  • Peripheral Neuropathy: Nerve damage that presents as numbness, tingling, weakness, or burning in the hands and feet. This is mainly associated with prolonged use in patients with poor kidney function.
  • Hemolytic Anemia: A condition where red blood cells are destroyed faster than they can be produced. Symptoms include fatigue, pale skin, rapid heartbeat, and dark urine. Patients with a deficiency in an enzyme called glucose-6-phosphate dehydrogenase (G6PD) are at a higher risk.
  • Clostridium difficile-Associated Diarrhea: Antibiotics can alter the normal intestinal microbiome, leading to the overgrowth of C. diff bacteria. Infection may range from mild diarrhea to fatal colitis. 

Who Should Avoid Nitrofurantoin?

According to drug manufacturing labels, the following people should not take nitrofurantoin:

  • Significant renal impairment (creatinine clearance under 60 mL/min or significantly elevated serum creatinine)
  • Anuria (urine output less than 100 mL/24 hours)
  • Oliguria (urine output less than 400 mL/24 hours)
  • Pregnant patients at term (38-42 weeks gestation), during labor and delivery, or when the onset of labor is imminent
  • Neonates under one-month-old
  • Medical history of liver dysfunction associated with nitrofurantoin
  • Known allergy to nitrofurantoin

Drug Interactions and Precautions

Antibiotics should only be used to treat bacterial infections. They do not treat viral infections. 

Macrobid is not indicated for treating complicated UTIs, including kidney infections, such as pyelonephritis or perinephric abscesses. If you begin to experience any of the following symptoms, call your doctor immediately: 

  • Fever and chills
  • Back, side, or groin pain
  • Nausea and vomiting

Nitrofurantoin can interact with other medications, increasing the risk of side effects or preventing the medicines from working well. Do not take nitrofurantoin with the following:

  • Antacids (used to treat heartburn) containing magnesium trisilicate interfere with the body's ability to absorb nitrofurantoin, reducing its efficacy.
  • Uricosuric drugs (used to lower uric acid levels in the blood), such as probenecid and sulfinpyrazone, interfere with how the body moves nitrofurantoin through the kidneys. This can cause higher levels of the drug in the blood, potentially increasing the risk of side effects. At the same time, because less nitrofurantoin is excreted in the urine, it may not be as effective at treating the UTI.

Alternative Treatments

When nitrofurantoin isn't the best treatment option, there are other options to consider for managing UTIs.

Other Antibiotics for UTIs

When choosing an antibiotic to treat an uncomplicated UTI, doctors consider several factors, including:

  • Antibiotic efficacy
  • Side effect profile
  • Rates of bacterial resistance
  • Cost and availability
  • Patient allergies

When nitrofurantoin is contraindicated, alternative antimicrobial agents for managing acute, uncomplicated cystitis include:

  • Fosfomycin
  • Trimethoprim-sulfamethoxazole 
  • Ciprofloxacin
  • Levofloxacin
  • Ofloxacin
  • Amoxicillin-clavulanate
  • Cefdinir
  • Cefpodoxime

Non-Antibiotic Approaches

Lifestyle habits help prevent UTIs:

  • Urinate before and after sexual activity
  • Wipe from front to back after having a bowel movement
  • Change menstrual products, such as pads and tampons, regularly
  • Avoid douching and applying deodorants on/in the vagina
  • Stay well hydrated by drinking at least 1.5 liters of water daily

Certain over-the-counter supplements can also support a healthy urinary tract:

  • According to a systematic review, daily probiotics, especially those containing Lactobacillus rhamnosus and reuteri, are associated with reduced UTI recurrence rates in women. 
  • Berberine is a plant-derived compound that has been shown to prevent bacterial (including E. coli) adhesion to human cells. 
  • Similarly, cranberry inhibits bacterial adhesion in the urinary tract, preventing bacterial growth and infection. According to a systematic review and meta-analysis, regular supplementation with cranberry reduced UTI incidence in at-risk populations.

FAQs About Nitrofurantoin

What Do I Do If I Miss a Dose?

If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. In that case, skip the missed dose and resume your regular schedule. Do not double up on doses to make up for a missed one.

Can Nitrofurantoin Be Used Long-Term?

Nitrofurantoin may be prescribed for long-term, prophylactic use under close medical supervision in specific cases, such as the prevention of recurrent UTIs.

Is Nitrofurantoin Safe for Elderly Patients?

Elderly patients may be at higher risk for side effects, particularly those related to the lungs and liver. As such, nitrofurantoin should be used cautiously in older adults, and the dosage may need to be adjusted depending on kidney function.

[signup]

Key Takeaways

  • Nitrofurantoin is an FDA-approved, first-line antibiotic for treating uncomplicated UTIs, especially those caused by E. coli bacteria.
  • Nitrofurantoin is often the preferred antibiotic for UTIs due to its high concentration in the urine, favorable safety profile, and low rates of bacterial resistance.
  • Its most common side effect includes gastrointestinal upset, which can often be prevented by taking the medication with food.
  • More serious side effects are rare but can occur. Always tell a doctor if you experience symptoms like severe diarrhea, fatigue, numbness and tingling, jaundice, cough, and shortness of breath. 
  • If you cannot take nitrofurantoin, discuss alternative antibiotics and natural remedies with your doctor for treating and preventing UTIs.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!
  1. Nitrofurantoin: Uses, Side Effects, Risks, and Safety Tips. (2024, December 4). Rupa Health. https://www.rupahealth.com/post/nitrofurantoin-side-effects-and-risks
  2. Adelman, M. (2024, February 9). Acid Reducers and Nutrient Absorption: What You Need to Know. Rupa Health. https://www.rupahealth.com/post/acid-reducers-and-nutrient-absorption-what-you-need-to-know
  3. Aggarwal, N., Leslie, S. W., & Lotfollahzadeh, S. (2022). Recurrent Urinary Tract Infections. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557479/
  4. Anuria. (2021, September 29). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/21890-anuria
  5. Bono, M. J., Reygaert, W. C., & Leslie, S. W. (2023, November 13). Uncomplicated Urinary Tract Infections. National Library of Medicine; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470195/
  6. Bryant, A. (2024, August 23). Chronic Clostridioides Difficile (C. diff): Understanding Symptoms, Treatment, and Long-Term Effects. Rupa Health. https://www.rupahealth.com/post/chronic-clostridioides-difficile-c-diff-understanding-symptoms-treatment-and-long-term-effects
  7. Bryant, A. (2025, January 9). Levofloxacin: Uses, Side Effects, and Safe Dosage Guidelines. Rupa Health. https://www.rupahealth.com/post/levofloxacin-uses-side-effects-and-safe-dosage-guidelines
  8. Cloyd, J. (2023, June 14). A Complementary and Integrative Medicine Approach to Reoccurring UTI's: Specialty Testing, Supplements, and Nutrition Options. Rupa Health. https://www.rupahealth.com/post/a-complementary-and-integrative-med-approach-to-reoccurring-utis-testing-supplements-and-nutrition-options
  9. Cloyd, J. (2023, June 28). Complementary and Integrative Medicine Options for Patients With Liver Disease: Comprehensive Lab Testing, Nutrition, and Supplement Suggestions. Rupa Health. https://www.rupahealth.com/post/a-functional-and-integrative-medicine-approach-to-treating-liver-disease-comprehensive-testing-nutrition-and-treatment-options
  10. Cloyd, J. (2023, July 13). A Functional Medicine UTI Protocol: Specialized Testing, Therapeutic Diet, and Supplements. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-uti-protocol-specialized-testing-therapeutic-diet-and-supplements
  11. Cloyd, J. (2023, September 8). Top Labs To Run Bi-Annually On Your Patients Who Suffer From Hepatitis. Rupa Health. https://www.rupahealth.com/post/top-labs-to-run-bi-annually-on-your-patients-who-suffer-from-hepatitis
  12. Cloyd, J. (2023, December 19). How to interpret your creatinine blood test. Rupa Health. https://www.rupahealth.com/post/how-to-interpret-your-creatinine-blood-test
  13. Cloyd, J. (2024, January 22). Interpreting Liver Enzyme Tests: ALT, AST, and ALP in Liver Health Monitoring. Rupa Health. https://www.rupahealth.com/post/interpreting-liver-enzyme-tests-alt-ast-and-alp-in-liver-health-monitoring
  14. Cloyd, J. (2024, December 19). Nitrofurantoin (Macrobid) 101: Uses, Effectiveness, and Safety Tips. Rupa Health. https://www.rupahealth.com/post/nitrofurantoin-macrobid-101-uses-effectiveness-and-safety-tips
  15. Colgan, R., & Williams, M. (2011). Diagnosis and Treatment of Acute Uncomplicated Cystitis. American Family Physician, 84(7), 771–776. https://www.aafp.org/pubs/afp/issues/2011/1001/p771.html#treatment
  16. Daglis, S. (2024, April 16). Berberine 101: What It Is, Benefits, and Side Effects. Rupa Health. https://www.rupahealth.com/post/berberine-101-what-it-is-benefits-and-side-effects
  17. Das, S. (2020). Natural therapeutics for urinary tract infections—a review. Future Journal of Pharmaceutical Sciences, 6(1). https://doi.org/10.1186/s43094-020-00086-2
  18. Falagas, M. E., Betsi, G. I., Tokas, T., et al. (2006). Probiotics for Prevention of Recurrent Urinary Tract Infections in Women. Drugs, 66(9), 1253–1261. https://doi.org/10.2165/00003495-200666090-00007
  19. Foxman, B., & Chi, J.-W. (1990). Health behavior and urinary tract infection in college-aged women. Journal of Clinical Epidemiology, 43(4), 329–337. https://doi.org/10.1016/0895-4356(90)90119-a
  20. FURADANTIN- nitrofurantoin suspension. (2024). DailyMed; National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=00af0dea-ac7b-43f2-9f51-2a9f9e7f7d21
  21. Haider, M. Z., & Aslam, A. (2023). Oliguria. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK560738/
  22. Howell, A. B., Reed, J. D., Krueger, C. G., et al. (2005). A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry, 66(18), 2281–2291. https://doi.org/10.1016/j.phytochem.2005.05.022
  23. Jancel, T., & Dudas, V. (2002). Management of uncomplicated urinary tract infections. Western Journal of Medicine, 176(1), 51–55. https://doi.org/10.1136/ewjm.176.1.51
  24. Kettlewell, R., Jones, C., Felton, T. W., et al. (2024). Insights into durability against resistance from the antibiotic nitrofurantoin. Npj Antimicrobials and Resistance, 2(1). https://doi.org/10.1038/s44259-024-00056-1
  25. Kidney infection. (2022, August 6). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/kidney-infection/symptoms-causes/syc-20353387
  26. MACROBID- nitrofurantoin monohydrate/macrocrystalline capsule. (n.d.). DailyMed; National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f270a9f-12a1-44d4-bc7e-873613555801
  27. MACRODANTIN- nitrofurantoin, macrocrystalline capsule. (2025). DailyMed; National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec86b651-d77d-4a42-b493-24244456b3f6#
  28. McOsker, C. C., & Fitzpatrick, P. M. (1994). Nitrofurantoin: Mechanism of action and implications for resistance development in common uropathogens. Journal of Antimicrobial Chemotherapy, 33(suppl A), 23–30. https://doi.org/10.1093/jac/33.suppl_a.23
  29. Nitrofurantoin Capsules or Tablets. Cleveland Clinic. https://my.clevelandclinic.org/health/drugs/18946-nitrofurantoin-capsules-or-tablets
  30. Olson, R. P., Harrell, L. J., & Kaye, K. S. (2009). Antibiotic Resistance in Urinary Isolates of Escherichia coli from College Women with Urinary Tract Infections. Antimicrobial Agents and Chemotherapy, 53(3), 1285–1286. https://doi.org/10.1128/aac.01188-08
  31. Robinson, K. (2024, November 26). Cefdinir: Effectiveness, Safety, & Alternatives. Rupa Health. https://www.rupahealth.com/post/cefdinir-effectiveness-safety-alternatives
  32. Scott, A. M., Clark, J., Mar, C. D., et al. (2020). Increased fluid intake to prevent urinary tract infections: systematic review and meta-analysis. British Journal of General Practice, 70(692), e200–e207. https://doi.org/10.3399/bjgp20x708125
  33. Shahbaz, H., Rout, P., & Gupta, M. (2023, May 20). Creatinine Clearance. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK544228/
  34. Squadrito, F. J., & del Portal, D. (2023, May 29). Nitrofurantoin. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK470526/
  35. Stauffer, K. (2024, December 11). Sulfamethoxazole-Trimethoprim: Uses, Dosage, and Side Effects. Rupa Health. https://www.rupahealth.com/post/sulfamethoxazole-trimethoprim-uses-dosage-and-side-effects
  36. ten Doesschate, T., Hendriks, K., van Werkhoven, C. H., et al. (2021). Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study. Clinical Microbiology and Infection, 28(2), 248–254. https://doi.org/10.1016/j.cmi.2021.05.048
  37. Uric Acid. (2020). Rupa Health. https://www.rupahealth.com/biomarkers/uric-acid#high
  38. Wilson, E. (2025, January 6). Antibiotics 101: A Medical Guide to Usage and Safety. Rupa Health. https://www.rupahealth.com/post/antibiotics-101-a-medical-guide-to-usage-and-safety
  39. Xia, J., Yang, C., Xu, D., et al. (2021). Consumption of cranberry as adjuvant therapy for urinary tract infections in susceptible populations: A systematic review and meta-analysis with trial sequential analysis. PLOS ONE, 16(9), e0256992. https://doi.org/10.1371/journal.pone.0256992
  40. Yang, X., Chen, H., Zheng, Y., et al. (2022). Disease burden and long-term trends of urinary tract infections: A worldwide report. Frontiers in Public Health, 10(888205). https://doi.org/10.3389/fpubh.2022.888205
  41. Yoshimura, H. (2023, June 29). Integrative Medicine Approaches to Neuropathic Pain Management: Specialty Testing and Treatment Options. Rupa Health. https://www.rupahealth.com/post/integrative-approach-to-neuropathic-pain-management
Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Immune Support
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.